| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 64.91 | 6.7% |
| Total Income | 64.91 | 6.7% |
| Expenditure | 66.71 | 18.3% |
| PBT | -6.81 | 26.0% |
| Net Profit | -6.63 | 34.4% |
| OPM | -2.77% | 14.50pp |
| NPM | -10.21% | 4.30pp |
| EPS | -0.05 | 37.5% |
SkinHealth Systems Reports Q1 2026 Net Sales of $64.9 Million, Adjusted EBITDA Up to $8.5 Million
08 May 2026 · 8 May, 1:50 am
Summary
SkinHealth Systems Inc. announced its first quarter 2026 financial results, reporting net sales of $64.9 million, a (6.7)% decline year-over-year. Despite the decrease in revenue, the company significantly narrowed its net loss to $(6.6) million and saw a notable improvement in adjusted EBITDA, which rose to $8.5 million from $7.3 million in the prior year, with adjusted EBITDA margin expanding to 13.1%. President and CEO Pedro Malha acknowledged the challenging market conditions and a lowered full-year revenue outlook, but affirmed the strength of the business fundamentals, growing installed base, and strong brand, alongside continued investments for long-term growth.
Key Highlights
- 1
SkinHealth Systems reported net sales of $64.9 million for the first quarter of 2026, representing a (6.7)% decrease compared to the prior year period.
- 2
The company significantly reduced its net loss to $(6.6) million in Q1 2026, an improvement from a net loss of $(10.1) million in Q1 2025.
- 3
Adjusted EBITDA increased to $8.5 million in Q1 2026 from $7.3 million in Q1 2025, with the adjusted EBITDA margin expanding to 13.1% from 10.4%.
- 4
Gross margin for Q1 2026 was 68.5%, a slight decrease from 69.8% in Q1 2025, while adjusted gross margin improved to 72.2% from 71.9%.
- 5
Total delivery systems sold in Q1 2026 were 746 units, down from 862 units in Q1 2025, though the active install base grew to 36,419.
- 6
The company revised its full-year 2026 net sales guidance to a range of $280 million to $295 million, reflecting continued pressure on device sales.
Management Comments
Pedro Malha
First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execution while continuing to invest in the capabilities and innovation that will drive long-term growth.
Informational and educational content only. Not investment advice.